Dr. Mirkin has served on the board since founding the Company in 2011. Dr. Mirkin is the Director of the International Institute for Nanotechnology at Northwestern University, as well as the George B. Rathmann Professor of Chemistry, Professor of Chemical and Biological Engineering, Professor of Biomedical Engineering, Professor of Materials Science and Engineering, and Professor of Medicine. As one of the most cited chemists and nanomedicine researchers in the world, Dr. Mirkin is one of very few scientists who are members of all three National Academies (NAS NAE, and NAM). He also currently serves as an advisor to President Obama on the President's Council of Advisors on Science and Technology (PCAST). Dr. Mirkin is known for his discovery and development of spherical nucleic acids (SNAs), the development of nanoparticle-based biodetection schemes, the invention of Dip-Pen Nanolithography, and many contributions to drug development. He is the author of over 650 manuscripts and over 1000 patents and applications (285 issued), and a founder of two other companies, Nanosphere (recently acquired by Luminex) and TERA-print, LLC. These companies have generated hundreds of products in the semiconductor and medical diagnostics arena, which are now sold and utilized worldwide. Dr. Mirkin has been recognized for his accomplishments with over 100 national and international awards, including the Dan David Prize, the NAS Sackler Prize in Convergence Science, and the $500,000 Lemelson MIT Prize. He is the founding editor of the journal Small, one of the premier international nanotechnology journals, has co-edited two bestselling books on nanobiotechnology, and has served on the Editorial Advisory Boards of over twenty scholarly journals. Dr. Mirkin holds a B.S. from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. in chemistry from the Pennsylvania State University (1989). He was an NSF Postdoctoral Fellow at the Massachusetts Institute of Technology prior to becoming a chemistry professor at Northwestern University in 1991.  

 Clinical Research & Bioethics